Definitive proxy statements

Pay vs Performance Disclosure

v3.25.2
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
Year   Summary Compensation Table Total for Dr. Mohan(1)     Compensation Actually Paid to Dr. Mohan(3)     Average Summary Compensation Table Total for Non-PEO NEOs(2)     Average Compensation Actually Paid to Non-PEO NEOs(3)     Value of Initial Fixed $100 Investment Based On Total Shareholder Return (“TSR”)(4)     Net Income (Loss) (millions)(5)  
(a)     (b)       (c)       (d)       (e)       (f)       (g)  
2024     626,626       585,791       413,231       404,168       29.14       (7,437,232 )
2023     1,022,720       508,988       622,830       415,486       8.81       (18,832,694 )
2022     1,005,393       676,266       609,894       262,233       16.15       (29,721,841 )
   
Named Executive Officers, Footnote [Text Block] The dollar amounts reported in column (b) are the amounts of total compensation reported for Dr. Mohan (our former Chief Executive Officer) for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation-Summary Compensation Table.”    
PEO Total Compensation Amount [1] $ 626,626 $ 1,022,720 $ 1,005,393
PEO Actually Paid Compensation Amount [2] $ 585,791 508,988 676,266
Adjustment To PEO Compensation, Footnote [Text Block]

 

Adjustments   Dr. Mohan ($)     Average Other NEOs ($)     Dr. Mohan ($)     Average Other NEOs ($)     Dr. Mohan ($)     Average Other NEOs ($)  
    2024     2023     2022  
Adjustments   Dr. Mohan ($)     Average Other NEOs ($)     Dr. Mohan ($)     Average Other NEOs ($)     Dr. Mohan ($)     Average Other NEOs ($)  
Deduction for amounts reported under the stock awards column in the summary compensation table     (87,628 )     (19,380 )     (405,648 )     (182,532 )     (362,741 )     (153,846 )
ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End     50,537       11,176       9,680       2,222       33,614       7,717  
ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date     -       -       -       -       -       -  
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End     -       -       -       -       -       -  
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date     (3,744 )     (859 )     (117,764 )     (27,035 )     -       -  
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End     -       -       -       -       -       -  
TOTAL ADJUSTMENTS     (40,835 )     (9,063 )     (513,732 )     (207,344 )     (329,127 )     (146,129 )
   
Non-PEO NEO Average Total Compensation Amount [3] $ 413,231 622,830 609,894
Non-PEO NEO Average Compensation Actually Paid Amount [2] $ 404,168 415,486 262,233
Compensation Actually Paid and Cumulative TSR

Compensation Actually Paid and Cumulative TSR

 

 

 

    
Compensation Actually Paid and Net Income (Loss)

Compensation Actually Paid and Net Income (Loss)

 

 

    
Total Shareholder Return Amount [4] $ 29.14 8.81 16.15
Net Income (Loss) Attributable to Parent [5] $ (7,437,232) $ (18,832,694) $ (29,721,841)
PEO Name Dr. Mohan Dr. Mohan Dr. Mohan
PEO [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS $ (40,835) $ (513,732) $ (329,127)
PEO [Member] | Deduction for Amounts Reported Under the Stock Awards Column in the Summary Compensation Table [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS (87,628) (405,648) (362,741)
PEO [Member] | ASC 718 Fair Value of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined as of Applicable FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS 50,537 9,680 33,614
PEO [Member] | ASC 718 Fair Value of Awards Granted During Applicable FY That Vested During Applicable FY, Determined as of Vesting Date [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
PEO [Member] | Increase/Deduction for Awards Granted During Prior FY that were Outstanding and Unvested as of Applicable FY End, Determined Based on Change in ASC 718 Fair Value from Prior FY End to Applicable FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
PEO [Member] | Increase/Deduction for Awards Granted During Prior FY that Vested During Applicable FY, Determined Based on Change in ASC 718 Fair Value from Prior FY End to Vesting Date [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS (3,744) (117,764)
PEO [Member] | Deduction of ASC 718 Fair Value of Awards Granted During Prior FY that were Forfeited During Applicable FY, Determined as of Prior FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
Non-PEO NEO [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS (9,063) (207,344) (146,129)
Non-PEO NEO [Member] | Deduction for Amounts Reported Under the Stock Awards Column in the Summary Compensation Table [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS (19,380) (182,532) (153,846)
Non-PEO NEO [Member] | ASC 718 Fair Value of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined as of Applicable FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS 11,176 2,222 7,717
Non-PEO NEO [Member] | ASC 718 Fair Value of Awards Granted During Applicable FY That Vested During Applicable FY, Determined as of Vesting Date [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
Non-PEO NEO [Member] | Increase/Deduction for Awards Granted During Prior FY that were Outstanding and Unvested as of Applicable FY End, Determined Based on Change in ASC 718 Fair Value from Prior FY End to Applicable FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
Non-PEO NEO [Member] | Increase/Deduction for Awards Granted During Prior FY that Vested During Applicable FY, Determined Based on Change in ASC 718 Fair Value from Prior FY End to Vesting Date [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS (859) (27,035)
Non-PEO NEO [Member] | Deduction of ASC 718 Fair Value of Awards Granted During Prior FY that were Forfeited During Applicable FY, Determined as of Prior FY End [Member]      
Pay vs Performance Disclosure [Table]      
TOTAL ADJUSTMENTS
[1] The dollar amounts reported in column (b) are the amounts of total compensation reported for Dr. Mohan (our former Chief Executive Officer) for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation-Summary Compensation Table.”
[2] Compensation actually paid to the named executive officers represents the “Total” compensation reported in the Summary Compensation Table for the applicable fiscal year, as adjusted as follows:
[3] The dollar amounts reported in column (d) represent the average of the amounts reported for our named executive officers as a group (excluding Dr. Mohan) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Dr. Mohan) included for purposes of calculating the average amounts in each applicable year are as follows: Jay Cross and John K. Cini.
[4] Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the price per share of our common stock at the end and the beginning of the measurement period by the price per share of our common stock at the beginning of the measurement period.
[5] The dollar amounts reported represent the amount of net income (loss) reflected in our consolidated audited financial statements for the applicable year.